These results, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the idea of targeting ACKR3 as a unique method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-relevant disorders. As well as the explained https://nigelw739neu5.wikimidpoint.com/user